alexa Randomised double-blind placebo-controlled trial of feverfew in migraine prevention.
Chemistry

Chemistry

Modern Chemistry & Applications

Author(s): Murphy JJ, Heptinstall S, Mitchell JR

Abstract Share this page

Abstract The use of feverfew (Tanacetum parthenium) for migraine prophylaxis was assessed in a randomised, double-blind, placebo-controlled crossover study. After a one-month single-blind placebo run-in, 72 volunteers were randomly allocated to receive either one capsule of dried feverfew leaves a day or matching placebo for four months and then transferred to the other treatment limb for a further four months. Frequency and severity of attacks were determined from diary cards which were issued every two months; efficacy of each treatment was also assessed by visual analogue scores. 60 patients completed the study and full information was available in 59. Treatment with feverfew was associated with a reduction in the mean number and severity of attacks in each two-month period, and in the degree of vomiting; duration of individual attacks was unaltered. Visual analogue scores also indicated a significant improvement with feverfew. There were no serious side-effects.
This article was published in Lancet and referenced in Modern Chemistry & Applications

Relevant Expert PPTs

Relevant Speaker PPTs

  • Eugene Stephane Mananga
    On Fer and Floquet-Magnus expansions: Application in solid-state nuclear magnetic resonance and physics
    PDF Version
  • Ines Bouaziz
    Water treatment containing organic compounds by coupling adsorption and electrochemical degradation at BDD anode: Sawdust adsorption performance for the treatment of dilute phenol solutions
    PPT Version | PDF Version
  • Beste Cubukcuoglu
    Beste-Cubukcuoglu-Antalya-International-University-Turkey-The-environmental-impact-evaluation-and-testing-of-sustainable-inorganic-binders-A-green-alternative-to-ordinary-Portland-cement
    PPT Version | PDF Version
  • Elizabeth Chang
    Advances in Internet of Things and Cyber Physical Systems and its Adoption to Smart Ship
    PPT Version | PDF Version
  • Soliman Khatib
    Analysis of volatile organic compounds in rats with dopaminergic lesion: possible application for early detection of Parkinson’s disease
    PPT Version | PDF Version
  • Paul A Levy
    Examining the Social and Physical Environment of Adolescent Substance Users in Shanghai and East Baltimore
    PPT Version | PDF Version
  • Yosef Yarden
    Classically, the 3’untranslated region (3’UTR) is that region in eukaryotic protein-coding genes from the translation termination codon to the polyA signal. It is transcribed as an integral part of the mRNA encoded by the gene. However, there exists another kind of RNA, which consists of the 3’UTR alone, without all other elements in mRNA such as 5’UTR and coding region. The importance of independent 3’UTR RNA (referred as I3’UTR) was prompted by results of artificially introducing such RNA species into malignant mammalian cells. Since 1991, we found that the middle part of the 3’UTR of the human nuclear factor for interleukin-6 (NF-IL6) or C/EBP gene exerted tumor suppression effect in vivo. Our subsequent studies showed that transfection of C/EBP 3’UTR led to down-regulation of several genes favorable for malignancy and to up-regulation of some genes favorable for phenotypic reversion. Also, it was shown that the sequences near the termini of the C/EBP 3’UTR were important for its tumor suppression activity. Then, the C/EBP 3’UTR was found to directly inhibit the phosphorylation activity of protein kinase CPKC in SMMC-7721, a hepatocarcinoma cell line. Recently, an AU-rich region in the C/EBP 3’UTR was found also to be responsible for its tumor suppression. Recently we have also found evidence that the independent C/EBP 3’UTR RNA is actually exists in human tissues, such as fetal liver and heart, pregnant uterus, senescent fibroblasts etc. Through 1990’s to 2000’s, world scientists found several 3’UTR RNAs that functioned as artificial independent RNAs in cancer cells and resulted in tumor suppression. Interestingly, majority of genes for these RNAs have promoter-like structures in their 3’UTR regions, although the existence of their transcribed products as independent 3’UTR RNAs is still to be confirmed. Our studies indicate that the independent 3’UTR RNA is a novel non-coding RNA species whose function should be the regulation not of the expression of their original mRNA, but of some essential life activities of the cell as a whole.
    PPT Version | PDF Version
  • Habiba Shehu
    Habiba-Shehu-Study-of-the-selectivity-of-methane-over-carbon-dioxide-and-inert-gases-using-composite-inorganic-membranes
    PPT Version | PDF Version
  • Yamina Andre
    Nanostructured self-assembled P3HT thin films and their application to enhance organic solar cell efficiency
    PPT Version | PDF Version
  • Daniel Smith
    The editor as auteur: The modern role of editors and preditors
    PPT Version | PDF Version
  • Nadia Badr
    Application of aquatic plant phytoremediation as green technology treatment of lead in polluted water
    PPT Version | PDF Version
  • Olga V Shuvaeva
    The use of thermal release technique with atomic absorption detection for the study of mercury transformation in contaminated environment
    PPT Version | PDF Version
  • Abel E Navarro
    Improving the adsorptive properties of biomaterials for the removal of heavy metals
    PPT Version | PDF Version
  • Dequan Xiao
    Inverse molecular design of green catalysts for biomass conversion
    PPT Version | PDF Version
  • Shenghong A Dai
    Green processes to diisocyanates and polyurethane-urea elastomers via carbonate raw materials: New NPR and NIR processes
    PPT Version | PDF Version

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords